{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T03:51:41Z","timestamp":1772164301798,"version":"3.50.1"},"reference-count":49,"publisher":"American Association for Cancer Research (AACR)","issue":"20","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,10,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Inactivating mutations in the tuberous sclerosis complex 2 (TSC2) gene, which encodes tuberin, result in the development of TSC and lymphangioleiomyomatosis (LAM). The tumor suppressor effect of tuberin lies in its GTPase-activating protein activity toward Ras homologue enriched in brain (Rheb), a Ras GTPase superfamily member. The statins, 3-hydroxy-3-methylglutaryl CoA reductase inhibitors, have pleiotropic effects which may involve interference with the isoprenylation of Ras and Rho GTPases. We show that atorvastatin selectively inhibits the proliferation of Tsc2\u2212\/\u2212 mouse embryo fibroblasts and ELT-3 smooth muscle cells in response to serum and estrogen, and under serum-free conditions. The isoprenoids farnesylpyrophosphate (FPP) and geranylgeranylpyrophosphate (GGPP) significantly reverse atorvastatin-induced inhibition of Tsc2\u2212\/\u2212 cell growth, suggesting that atorvastatin dually targets a farnesylated protein, such as Rheb, and a geranylgeranylated protein, such as Rho, both of which have elevated activity in Tsc2\u2212\/\u2212 cells. Atorvastatin reduced Rheb isoprenylation, GTP loading, and membrane localization. Atorvastatin also inhibited the constitutive phosphorylation of mammalian target of rapamycin, S6 kinase, and S6 found in Tsc2\u2212\/\u2212 cells in an FPP-reversible manner and attenuated the high levels of phosphorylated S6 in Tsc2-heterozygous mice. Atorvastatin, but not rapamycin, attenuated the increased levels of activated RhoA in Tsc2\u2212\/\u2212 cells, and this was reversed by GGPP. These results suggest that atorvastatin may inhibit both rapamycin-sensitive and rapamycin-insensitive mechanisms of tuberin-null cell growth, likely via Rheb and Rho inhibition, respectively. Atorvastatin may have potential therapeutic benefit in TSC syndromes, including LAM. [Cancer Res 2007;67(20):9878\u201386]<\/jats:p>","DOI":"10.1158\/0008-5472.can-07-1394","type":"journal-article","created":{"date-parts":[[2007,10,17]],"date-time":"2007-10-17T17:39:01Z","timestamp":1192642741000},"page":"9878-9886","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Selective Inhibition of Growth of\n                    <i>Tuberous Sclerosis Complex 2<\/i>\n                    \u2013Null Cells by Atorvastatin Is Associated with Impaired Rheb and Rho GTPase Function and Reduced mTOR\/S6 Kinase Activity"],"prefix":"10.1158","volume":"67","author":[{"given":"Geraldine A.","family":"Finlay","sequence":"first","affiliation":[{"name":"1Pulmonary and Critical Care Division, Department of Medicine, Tupper Research Institute, Tufts-New England Medical Center;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy J.","family":"Malhowski","sequence":"additional","affiliation":[{"name":"1Pulmonary and Critical Care Division, Department of Medicine, Tupper Research Institute, Tufts-New England Medical Center;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingling","family":"Liu","sequence":"additional","affiliation":[{"name":"1Pulmonary and Critical Care Division, Department of Medicine, Tupper Research Institute, Tufts-New England Medical Center;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry L.","family":"Fanburg","sequence":"additional","affiliation":[{"name":"1Pulmonary and Critical Care Division, Department of Medicine, Tupper Research Institute, Tufts-New England Medical Center;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Kwiatkowski","sequence":"additional","affiliation":[{"name":"2Division of Translational Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deniz","family":"Toksoz","sequence":"additional","affiliation":[{"name":"1Pulmonary and Critical Care Division, Department of Medicine, Tupper Research Institute, Tufts-New England Medical Center;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1086","published-online":{"date-parts":[[2007,10,17]]},"reference":[{"key":"2022061623191142100_B1","doi-asserted-by":"crossref","unstructured":"The European Chromosome 16 Tuberous Sclerosis Consortium. Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell\u20081993; 75: 1305\u201315.","DOI":"10.1016\/0092-8674(93)90618-Z"},{"key":"2022061623191142100_B2","doi-asserted-by":"crossref","unstructured":"van Slegtenhorst M, de Hoogt R, Hermans C, et al. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science\u20081997; 277: 805\u20138.","DOI":"10.1126\/science.277.5327.805"},{"key":"2022061623191142100_B3","doi-asserted-by":"crossref","unstructured":"Li Y, Corradetti MN, Inoki K, Guan KL. TSC2: filling the GAP in the mTOR signaling pathway. Trends Biochem Sci\u20082004; 29: 32\u20138.","DOI":"10.1016\/j.tibs.2003.11.007"},{"key":"2022061623191142100_B4","doi-asserted-by":"crossref","unstructured":"Li Y, Inoki K, Guan KL. Biochemical and functional characterizations of small GTPase Rheb and TSC2 GAP activity. Mol Cell Biol\u20082004; 24: 7965\u201375.","DOI":"10.1128\/MCB.24.18.7965-7975.2004"},{"key":"2022061623191142100_B5","doi-asserted-by":"crossref","unstructured":"Aspuria PJ, Tamanoi F. The Rheb family of GTP-binding proteins. Cell Signal\u20082004; 16: 1105\u201312.","DOI":"10.1016\/j.cellsig.2004.03.019"},{"key":"2022061623191142100_B6","doi-asserted-by":"crossref","unstructured":"Inoki K, Li Y, Zhu T, Wu J, Guan KL. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat Cell Biol\u20082002; 4: 648\u201357.","DOI":"10.1038\/ncb839"},{"key":"2022061623191142100_B7","doi-asserted-by":"crossref","unstructured":"Potter CJ, Huang H, Xu T. Drosophila Tsc1 functions with Tsc2 to antagonize insulin signaling in regulating cell growth, cell proliferation, and organ size. Cell\u20082001; 105: 357\u201368.","DOI":"10.1016\/S0092-8674(01)00333-6"},{"key":"2022061623191142100_B8","doi-asserted-by":"crossref","unstructured":"Tapon N, Ito N, Dickson BJ, Treisman JE, Hariharan IK. The Drosophila tuberous sclerosis complex gene homologs restrict cell growth and cell proliferation. Cell\u20082001; 105: 345\u201355.","DOI":"10.1016\/S0092-8674(01)00332-4"},{"key":"2022061623191142100_B9","doi-asserted-by":"crossref","unstructured":"Goncharova EA, Goncharov DA, Eszterhas A, et al. Tuberin regulates p70 S6 kinase activation and ribosomal protein S6 phosphorylation: a role for the TSC2 tumor suppressor gene in pulmonary lymphangioleiomyomatosis (LAM). J Biol Chem\u20082002; 3: 3.","DOI":"10.1074\/jbc.M202678200"},{"key":"2022061623191142100_B10","doi-asserted-by":"crossref","unstructured":"Jozwiak J, Jozwiak S, Oldak M. Molecular activity of sirolimus and its possible application in tuberous sclerosis treatment. Med Res Rev\u20082006; 26: 160\u201380.","DOI":"10.1002\/med.20049"},{"key":"2022061623191142100_B11","doi-asserted-by":"crossref","unstructured":"Manning BD, Logsdon MN, Lipovsky AI, Abbott D, Kwiatkowski DJ, Cantley LC. Feedback inhibition of Akt signaling limits the growth of tumors lacking Tsc2. Genes Dev\u20082005; 19: 1773\u20138.","DOI":"10.1101\/gad.1314605"},{"key":"2022061623191142100_B12","doi-asserted-by":"crossref","unstructured":"O'Reilly KE, Rojo F, She QB, et al. mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt. Cancer Res\u20082006; 66: 1500\u20138.","DOI":"10.1158\/0008-5472.CAN-05-2925"},{"key":"2022061623191142100_B13","doi-asserted-by":"crossref","unstructured":"Sun SY, Rosenberg LM, Wang X, et al. Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition. Cancer Res\u20082005; 65: 7052\u20138.","DOI":"10.1158\/0008-5472.CAN-05-0917"},{"key":"2022061623191142100_B14","doi-asserted-by":"crossref","unstructured":"Adamson P, Marshall CJ, Hall A, Tilbrook PA. Post-translational modifications of p21rho proteins. J Biol Chem\u20081992; 267: 20033\u20138.","DOI":"10.1016\/S0021-9258(19)88661-1"},{"key":"2022061623191142100_B15","doi-asserted-by":"crossref","unstructured":"Zhang FL, Casey PJ. Protein prenylation: molecular mechanisms and functional consequences. Annu Rev Biochem\u20081996; 65: 241\u201369.","DOI":"10.1146\/annurev.bi.65.070196.001325"},{"key":"2022061623191142100_B16","doi-asserted-by":"crossref","unstructured":"Jaffe AB, Hall A. Rho GTPases: biochemistry and biology. Annu Rev Cell Dev Biol\u20082005; 21: 247\u201369.","DOI":"10.1146\/annurev.cellbio.21.020604.150721"},{"key":"2022061623191142100_B17","doi-asserted-by":"crossref","unstructured":"Castro AF, Rebhun JF, Clark GJ, Quilliam LA. Rheb binds tuberous sclerosis complex 2 (TSC2) and promotes S6 kinase activation in a rapamycin- and farnesylation-dependent manner. J Biol Chem\u20082003; 278: 32493\u20136.","DOI":"10.1074\/jbc.C300226200"},{"key":"2022061623191142100_B18","doi-asserted-by":"crossref","unstructured":"Long X, Lin Y, Ortiz-Vega S, Yonezawa K, Avruch J. Rheb binds and regulates the mTOR kinase. Curr Biol\u20082005; 15: 702\u201313.","DOI":"10.1016\/j.cub.2005.02.053"},{"key":"2022061623191142100_B19","doi-asserted-by":"crossref","unstructured":"Tee AR, Manning BD, Roux PP, Cantley LC, Blenis J. Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb. Curr Biol\u20082003; 13: 1259\u201368.","DOI":"10.1016\/S0960-9822(03)00506-2"},{"key":"2022061623191142100_B20","doi-asserted-by":"crossref","unstructured":"Grundy SM. HMG-CoA reductase inhibitors for treatment of hypercholesterolemia. N Engl J Med\u20081988; 319: 24\u201333.","DOI":"10.1056\/NEJM198807073190105"},{"key":"2022061623191142100_B21","doi-asserted-by":"crossref","unstructured":"Goldstein JL, Brown MS. Regulation of the mevalonate pathway. Nature\u20081990; 343: 425\u201330.","DOI":"10.1038\/343425a0"},{"key":"2022061623191142100_B22","doi-asserted-by":"crossref","unstructured":"Liao JK, Laufs U. Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol\u20082005; 45: 89\u2013118.","DOI":"10.1146\/annurev.pharmtox.45.120403.095748"},{"key":"2022061623191142100_B23","doi-asserted-by":"crossref","unstructured":"Goncharova E, Goncharov D, Noonan D, Krymskaya VP. TSC2 modulates actin cytoskeleton and focal adhesion through TSC1-binding domain and the Rac1 GTPase. J Cell Biol\u20082004; 167: 1171\u201382.","DOI":"10.1083\/jcb.200405130"},{"key":"2022061623191142100_B24","doi-asserted-by":"crossref","unstructured":"Finlay GA, York B, Karas RH, et al. Estrogen-induced smooth muscle cell growth is regulated by tuberin and associated with altered activation of PDGFR-\u03b2 and ERK-1\/2. J Biol Chem\u20082004; 23: 23.","DOI":"10.1074\/jbc.M401912200"},{"key":"2022061623191142100_B25","doi-asserted-by":"crossref","unstructured":"Kwiatkowski DJ, Zhang H, Bandura JL, et al. A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells. Hum Mol Genet\u20082002; 11: 525\u201334.","DOI":"10.1093\/hmg\/11.5.525"},{"key":"2022061623191142100_B26","doi-asserted-by":"crossref","unstructured":"Kim DH, Sarbassov DD, Ali SM, et al. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell\u20082002; 110: 163\u201375.","DOI":"10.1016\/S0092-8674(02)00808-5"},{"key":"2022061623191142100_B27","doi-asserted-by":"crossref","unstructured":"Sterpetti P, Hack AA, Bashar MP, et al. Activation of the Lbc Rho exchange factor proto-oncogene by truncation of an extended C terminus that regulates transformation and targeting. Mol Cell Biol\u20081999; 19: 1334\u201345.","DOI":"10.1128\/MCB.19.2.1334"},{"key":"2022061623191142100_B28","doi-asserted-by":"crossref","unstructured":"Demierre MF, Higgins PD, Gruber SB, Hawk E, Lippman SM. Statins and cancer prevention. Nat Rev Cancer\u20082005; 5: 930\u201342.","DOI":"10.1038\/nrc1751"},{"key":"2022061623191142100_B29","doi-asserted-by":"crossref","unstructured":"Yang Q, Inoki K, Kim E, Guan KL. TSC1\/TSC2 and Rheb have different effects on TORC1 and TORC2 activity. Proc Natl Acad Sci U S A\u20082006; 103: 6811\u20136.","DOI":"10.1073\/pnas.0602282103"},{"key":"2022061623191142100_B30","doi-asserted-by":"crossref","unstructured":"Finlay GA, Thannickal VJ, Fanburg BL, Kwiatkowski DJ. Platelet-derived growth factor-induced p42\/44 mitogen-activated protein kinase activation and cellular growth is mediated by reactive oxygen species in the absence of TSC2\/tuberin. Cancer Res\u20082005; 65: 10881\u201390.","DOI":"10.1158\/0008-5472.CAN-05-1394"},{"key":"2022061623191142100_B31","doi-asserted-by":"crossref","unstructured":"Yan L, Findlay GM, Jones R, Procter J, Cao Y, Lamb RF. Hyperactivation of mammalian target of rapamycin (mTOR) signaling by a gain-of-function mutant of the Rheb GTPase. J Biol Chem\u20082006; 281: 19793\u20137.","DOI":"10.1074\/jbc.C600028200"},{"key":"2022061623191142100_B32","doi-asserted-by":"crossref","unstructured":"Silva M, Matthews ML, Jarvis C, et al. Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy. Clin Ther\u20082007; 29: 253\u201360.","DOI":"10.1016\/j.clinthera.2007.02.008"},{"key":"2022061623191142100_B33","doi-asserted-by":"crossref","unstructured":"Buemi M, Allegra A, Senatore M, et al. Pro-apoptotic effect of fluvastatin on human smooth muscle cells. Eur J Pharmacol\u20081999; 370: 201\u20133.","DOI":"10.1016\/S0014-2999(99)00122-3"},{"key":"2022061623191142100_B34","doi-asserted-by":"crossref","unstructured":"Yu J, Henske EP. Estrogen-induced activation of mammalian target of rapamycin is mediated via tuberin and the small GTPase Ras homologue enriched in brain. Cancer Res\u20082006; 66: 9461\u20136.","DOI":"10.1158\/0008-5472.CAN-06-1895"},{"key":"2022061623191142100_B35","doi-asserted-by":"crossref","unstructured":"Campbell MJ, Esserman LJ, Zhou Y, et al. Breast cancer growth prevention by statins. Cancer Res\u20082006; 66: 8707\u201314.","DOI":"10.1158\/0008-5472.CAN-05-4061"},{"key":"2022061623191142100_B36","doi-asserted-by":"crossref","unstructured":"Mueck AO, Seeger H, Wallwiener D. Effect of statins combined with estradiol on the proliferation of human receptor-positive and receptor-negative breast cancer cells. Menopause\u20082003; 10: 332\u20136.","DOI":"10.1097\/01.GME.0000055485.06076.00"},{"key":"2022061623191142100_B37","doi-asserted-by":"crossref","unstructured":"Seeger H, Wallwiener D, Mueck AO. Statins can inhibit proliferation of human breast cancer cells in vitro. Exp Clin Endocrinol Diabetes\u20082003; 111: 47\u20138.","DOI":"10.1055\/s-2003-37501"},{"key":"2022061623191142100_B38","doi-asserted-by":"crossref","unstructured":"Cordle A, Koenigsknecht-Talboo J, Wilkinson B, Limpert A, Landreth G. Mechanisms of statin-mediated inhibition of small G-protein function. J Biol Chem\u20082005; 280: 34202\u20139.","DOI":"10.1074\/jbc.M505268200"},{"key":"2022061623191142100_B39","doi-asserted-by":"crossref","unstructured":"Buerger C, DeVries B, Stambolic V. Localization of Rheb to the endomembrane is critical for its signaling function. Biochem Biophys Res Commun\u20082006; 344: 869\u201380.","DOI":"10.1016\/j.bbrc.2006.03.220"},{"key":"2022061623191142100_B40","doi-asserted-by":"crossref","unstructured":"Cai SL, Tee AR, Short JD, et al. Activity of TSC2 is inhibited by AKT-mediated phosphorylation and membrane partitioning. J Cell Biol\u20082006; 173: 279\u201389.","DOI":"10.1083\/jcb.200507119"},{"key":"2022061623191142100_B41","doi-asserted-by":"crossref","unstructured":"Clark GJ, Kinch MS, Rogers-Graham K, Sebti SM, Hamilton AD, Der CJ. The Ras-related protein Rheb is farnesylated and antagonizes Ras signaling and transformation. J Biol Chem\u20081997; 272: 10608\u201315.","DOI":"10.1074\/jbc.272.16.10608"},{"key":"2022061623191142100_B42","doi-asserted-by":"crossref","unstructured":"Takahashi K, Nakagawa M, Young SG, Yamanaka S. Differential membrane localization of ERas and Rheb, two Ras-related proteins involved in the phosphatidylinositol 3-kinase\/mTOR pathway. J Biol Chem\u20082005; 280: 32768\u201374.","DOI":"10.1074\/jbc.M506280200"},{"key":"2022061623191142100_B43","doi-asserted-by":"crossref","unstructured":"Paterson HF, Self AJ, Garrett MD, Just I, Aktories K, Hall A. Microinjection of recombinant p21rho induces rapid changes in cell morphology. J Cell Biol\u20081990; 111: 1001\u20137.","DOI":"10.1083\/jcb.111.3.1001"},{"key":"2022061623191142100_B44","doi-asserted-by":"crossref","unstructured":"Koch G, Benz C, Schmidt G, Olenik C, Aktories K. Role of Rho protein in lovastatin-induced breakdown of actin cytoskeleton. J Pharmacol Exp Ther\u20081997; 283: 901\u20139.","DOI":"10.1016\/S0022-3565(24)37069-7"},{"key":"2022061623191142100_B45","doi-asserted-by":"crossref","unstructured":"Loucks FA, Le SS, Zimmermann AK, et al. Rho family GTPase inhibition reveals opposing effects of mitogen-activated protein kinase kinase\/extracellular signal-regulated kinase and Janus kinase\/signal transducer and activator of transcription signaling cascades on neuronal survival. J Neurochem\u20082006; 97: 957\u201367.","DOI":"10.1111\/j.1471-4159.2006.03802.x"},{"key":"2022061623191142100_B46","doi-asserted-by":"crossref","unstructured":"El-Hashemite N, Kwiatkowski DJ. Interferon-\u03b3-Jak-Stat signaling in pulmonary lymphangioleiomyomatosis and renal angiomyolipoma: a potential therapeutic target. Am J Respir Cell Mol Biol\u20082005; 33: 227\u201330.","DOI":"10.1165\/rcmb.2005-0152RC"},{"key":"2022061623191142100_B47","doi-asserted-by":"crossref","unstructured":"Jacinto E, Loewith R, Schmidt A, et al. Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat Cell Biol\u20082004; 6: 1122\u20138.","DOI":"10.1038\/ncb1183"},{"key":"2022061623191142100_B48","doi-asserted-by":"crossref","unstructured":"Horiguchi A, Sumitomo M, Asakuma J, Asano T, Asano T, Hayakawa M. 3-Hydroxy-3-methylglutaryl-coenzyme a reductase inhibitor, fluvastatin, as a novel agent for prophylaxis of renal cancer metastasis. Clin Cancer Res\u20082004; 10: 8648\u201355.","DOI":"10.1158\/1078-0432.CCR-04-1568"},{"key":"2022061623191142100_B49","doi-asserted-by":"crossref","unstructured":"Wendel HG, De Stanchina E, Fridman JS, et al. Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy. Nature\u20082004; 428: 332\u20137.","DOI":"10.1038\/nature02369"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/20\/9878\/2576224\/9878.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/20\/9878\/2576224\/9878.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T13:43:07Z","timestamp":1737466987000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/67\/20\/9878\/533803\/Selective-Inhibition-of-Growth-of-Tuberous"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10,15]]},"references-count":49,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2007,10,17]]},"published-print":{"date-parts":[[2007,10,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-07-1394","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6496451.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6496451","asserted-by":"object"}],"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.22370594","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22370594.v1","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10,15]]}}}